FragmentStore-a comprehensive database of fragments linking metabolites, toxic molecules and drugs

被引:16
作者
Ahmed, Jessica [1 ]
Worth, Catherine L. [1 ]
Thaben, Paul [1 ]
Matzig, Christian [1 ]
Blasse, Corinna [1 ]
Dunkel, Mathias [1 ]
Preissner, Robert [1 ]
机构
[1] Charite, Inst Physiol, Struct Bioinformat Grp, D-13125 Berlin, Germany
关键词
PREDICTION; DESIGN; KEGG;
D O I
10.1093/nar/gkq969
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Consideration of biomolecules in terms of their molecular building blocks provides valuable new information regarding their synthesis, degradation and similarity. Here, we present the FragmentStore, a resource for the comparison of fragments found in metabolites, drugs or toxic compounds. Starting from 13 000 metabolites, 16 000 drugs and 2200 toxic compounds we generated 35 000 different building blocks (fragments), which are not only relevant to their biosynthesis and degradation but also provide important information regarding side-effects and toxicity. The FragmentStore provides a variety of search options such as 2D structure, molecular weight, rotatable bonds, etc. Various analysis tools have been implemented including the calculation of amino acid preferences of fragments' binding sites, classification of fragments based on the enzyme classification class of the enzyme(s) they bind to and small molecule library generation via a fragment-assembler tool. Using the FragmentStore, it is now possible to identify the common fragments of different classes of molecules and generate hypotheses about the effects of such intersections. For instance, the co-occurrence of fragments in different drugs may indicate similar targets and possible off-target interactions whereas the co-occurrence of fragments in a drug and a toxic compound/metabolite could be indicative of side-effects. The database is publicly available at: http://bioinformatics.charite.de/fragment_store.
引用
收藏
页码:D1049 / D1054
页数:6
相关论文
共 24 条
[1]  
[Anonymous], PYMOL MOL GRAPHICS S
[2]   Computational analysis of ligand relationships within target families [J].
Bajorath, Juergen .
CURRENT OPINION IN CHEMICAL BIOLOGY, 2008, 12 (03) :352-358
[3]   The Protein Data Bank [J].
Berman, HM ;
Westbrook, J ;
Feng, Z ;
Gilliland, G ;
Bhat, TN ;
Weissig, H ;
Shindyalov, IN ;
Bourne, PE .
NUCLEIC ACIDS RESEARCH, 2000, 28 (01) :235-242
[4]   PubChem as a Source of Polypharmacology [J].
Chen, Bin ;
Wild, David ;
Guha, Rajarshi .
JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2009, 49 (09) :2044-2055
[5]  
Committee on Toxicity Testing and Assessment of Environmental Agents National Research Council of The National Academies, 2007, TOX TEST 21 CENT VIS
[6]   A rule of three for fragment-based lead discovery? [J].
Congreve, M ;
Carr, R ;
Murray, C ;
Jhoti, H .
DRUG DISCOVERY TODAY, 2003, 8 (19) :876-877
[7]  
Enna SJ, 2009, ADV PHARMACOL, V57, pXI
[8]   A decade of fragment-based drug design: strategic advances and lessons learned [J].
Hajduk, Philip J. ;
Greer, Jonathan .
NATURE REVIEWS DRUG DISCOVERY, 2007, 6 (03) :211-219
[9]  
Kanehisa M, 2002, NOVART FDN SYMP, V247, P91
[10]   KEGG for representation and analysis of molecular networks involving diseases and drugs [J].
Kanehisa, Minoru ;
Goto, Susumu ;
Furumichi, Miho ;
Tanabe, Mao ;
Hirakawa, Mika .
NUCLEIC ACIDS RESEARCH, 2010, 38 :D355-D360